NewsRx

Search our medical news database

Business Update

Investment firm starts diabetes device company coverage with outperform rating

Published in Obesity and Diabetes Week, July 4th, 2005

William Blair & Company announced that it initiated research coverage of DexCom, Inc. (DXCM), which has developed a continuous glucose sensor technology to help diabetics better manage their disease, with an outperform rating and company profile of aggressive growth.

Analyst Ben Andrew estimated that the company, whose first product, a short-term sensor, is under expedited review by the U.S. Food and Drug Administration (FDA) and could reach the domestic market in second quarter 2006, would generate revenues of $10 million in 2006, $63 million in 2007, and $160 million in 2008, with the company turning profitable in third quarter 2007.

William Blair...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook